The ZFP57 gene helps an early embryo keep certain chemical tags on DNA in place, so a small group of genes stay switched on or off at the right time. If the ZFP57 gene does not work properly, these tags can be lost, which may disturb growth and blood sugar control and can cause transient neonatal diabetes, a form of diabetes that begins in the first weeks of life and may improve for a time.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some provide the information needed to make proteins, which do much of the work inside cells. Others mainly direct when, where, and how strongly certain processes take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
ZFP57Gene function
What if the gene works
The ZFP57 gene helps preserve parent specific chemical marks on DNA during early development. This helps certain genes turn on or off at the right time, supporting normal growth and body development.
Risk
What if the gene does not work
Variants in the ZFP57 gene can disrupt genomic imprinting, the chemical marking system that controls gene activity. More severe variants often cause transient neonatal diabetes in newborns and may also affect growth or development, while milder variants can have less noticeable effects.
Treatment
What does that mean for your treatment
No ZFP57-specific treatment or drug selection strategy is currently established; care is guided by the person’s symptoms and standard treatment for the condition present.
Conditions associated with ZFP57
Gene function
What if the gene works
In the earliest days of life, cells need a reliable way to remember which parent a few important genes came from. The ZFP57 gene helps preserve that memory so early development follows the right plan. Understanding how the ZFP57 gene helps control early development also shows why these inherited instruction marks matter.
ZFP57 helps cells remember whether they should use the mother’s copy or the father’s copy of certain genes. This parent specific pattern, called imprinting, is a normal part of human growth.
It attaches to DNA sites that carry special chemical tags and helps those tags stay in place as cells divide. This gives new cells a stable record of important instructions.
Soon after conception, many control marks in DNA are reset, but some need to be preserved. ZFP57 helps protect these selected marks during very early development.
By working with helper proteins, ZFP57 helps keep some imprinted genes quieter when needed. This supports the normal balance between the two parental copies.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In practical terms, how ZFP57 gene variants affect function depends on whether a change weakens the protein slightly or largely shuts it down. Many variants reduce DNA binding or disrupt its interaction with TRIM28, which can lead to loss of methylation, the chemical tags that keep imprinted genes regulated. Milder variants may leave some activity. More severe variants can cause broader methylation loss and, in some infants, earlier or more noticeable features such as transient neonatal diabetes.
How variants are linked to conditions
Pathogenic variants in the ZFP57 gene can cause a rare form of transient neonatal diabetes, often recognized in the first weeks of life. In many affected babies, blood sugar is high soon after birth, improves during infancy, and may return later in childhood or adulthood. Some people with ZFP57-related neonatal diabetes also have poor growth before birth or other findings linked to imprinting conditions. A confirmed harmful variant in both copies of the ZFP57 gene can confirm this diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In contrast, a single well understood variant in a particular gene can sometimes be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the ZFP57 gene. In families with a disease-causing ZFP57 change, risk is mainly shaped by the inherited genetic change itself rather than lifestyle or everyday exposures.
Inheritance of ZFP57 variants
ZFP57-related conditions are inherited in an autosomal recessive pattern. In practical terms, how ZFP57 gene variants are inherited usually means a child must receive one variant in the ZFP57 gene from each parent to be affected. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This inheritance pattern is the well-established one for ZFP57-related disease.
What does my ZFP57 result mean for my family?
For families with a disease-causing change in the ZFP57 gene, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be carriers, and in some families a sibling could be affected if they inherited the changed gene from both parents. Close relatives may want to learn whether carrier testing is relevant for family planning.
Genetic information
Genetic testing
How you find out about variants
Variants in the ZFP57 gene are found with genetic testing, usually from a blood sample and sometimes saliva. If you are having genetic testing for ZFP57 variants, a lab reads the gene’s DNA code, often as part of a multigene panel or exome test, to look for changes that may help explain the result.
When should I consider getting a genetic test?
Consider genetic testing for the ZFP57 gene if a baby develops diabetes in the first 6 months of life, especially if blood sugar later settles down or there is a family history of very early diabetes. Finding a ZFP57 change can help explain a rare form of newborn diabetes and clarify the chance of it happening again in the family.
A genetic result is only one part of your health story
A genetic result may provide useful insight, although what it can tell you depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have less effect in another, or be more likely to cause side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. More details on this topic are available in the LearnHub.
Drugs influenced by the ZFP57 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so concerns about side effects, medicine changes, or how treatment fits your overall health are best discussed with your doctor or pharmacist.
History
ZFP57 entered genetics research as scientists worked to explain why some genes keep parent-specific activity patterns after fertilization, a key question in genomic imprinting. Initially understood only through visible traits, later recognized as tied to a specific gene, ZFP57 became closely linked to rare cases of transient neonatal diabetes in the late 2000s. From these first observations, research expanded steadily. Studies then showed that changes in the ZFP57 gene could disrupt the chemical marks that help certain genes stay switched on or off in the right parent-of-origin pattern. This helped place ZFP57 in the broader history of epigenetics, the field that studies how genes are regulated without changing the DNA code itself.